FDA approves Pfizer's Braftovi plus Mektovi for a type of non-small cell lung cancer

Pfizer Inc. said Thursday the U.S. Food and Drug Administration has approved its Braftovi plus Mektovi combination therapy as a treatment for patients with...

Related Keywords

Canada ,Japan ,United States ,South Korea ,Israel ,America ,Gregory Riely ,Pierre Fabre ,Pfizer Inc ,Ono Pharmaceutical Co ,Drug Administration ,Pfizer ,Memorial Sloan Kettering Cancer Center ,Latin America ,Ono Pharmaceutical ,Article Normal ,Pharmaceuticals ,Regulation Government Policy ,Pfe ,Ono Pharmaceutical Co Ltd ,Jp 4528 ,Spx ,S Amp Ampp 500 Index ,Regulation ,Government Policy ,